Braulio Muñoz
University of Concepción
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Braulio Muñoz.
Journal of Neurochemistry | 2011
Christian Peters; Braulio Muñoz; Fernando J. Sepúlveda; Juan C. Urrutia; Mauricio Quiroz; Sandra Luza; Giancarlo V. De Ferrari; Luis G. Aguayo; Carlos Opazo
J. Neurochem. (2011) 119, 78–88.
Neuropsychopharmacology | 2014
Luis G. Aguayo; Patricio Castro; Trinidad Mariqueo; Braulio Muñoz; Wei Xiong; Li Zhang; David M. Lovinger; Gregg E. Homanics
Alcohol abuse and alcoholism are major health problems and one of the leading preventable causes of death. Before achieving better treatments for alcoholism, it is necessary to understand the critical actions of alcohol on membrane proteins that regulate fundamental functions in the central nervous system. After generating a genetically modified knock-in (KI) mouse having a glycine receptor (GlyR) with phenotypical silent mutations at KK385/386AA, we studied its cellular and in vivo ethanol sensitivity. Analyses with western blotting and immunocytochemistry indicated that the expression of α1 GlyRs in nervous tissues and spinal cord neurons (SCNs) were similar between WT and KI mice. The analysis of synaptic currents recorded from KI mice showed that the glycinergic synaptic transmission had normal properties, but the sensitivity to ethanol was significantly reduced. Furthermore, the glycine-evoked current in SCNs from KI was resistant to ethanol and G-protein activation by GTP-γ-S. In behavioral studies, KI mice did not display the foot-clasping behavior upon lifting by the tail and lacked an enhanced startle reflex response that are characteristic of other glycine KI mouse lines with markedly impaired glycine receptor function. The most notable characteristic of the KI mice was their significant lower sensitivity to ethanol (∼40%), expressed by shorter times in loss of righting reflex (LORR) in response to a sedative dose of ethanol (3.5 g/Kg). These data provide the first evidence to link a molecular site in the GlyR with the sedative effects produced by intoxicating doses of ethanol.
Journal of Clinical Investigation | 2016
Mario A. Acuña; Gonzalo E. Yévenes; William T. Ralvenius; Dietmar Benke; Alessandra Di Lio; Cesar O. Lara; Braulio Muñoz; Carlos F. Burgos; Gustavo Moraga-Cid; Pierre-Jean Corringer; Hanns Ulrich Zeilhofer
Diminished inhibitory neurotransmission in the superficial dorsal horn of the spinal cord is thought to contribute to chronic pain. In inflammatory pain, reductions in synaptic inhibition occur partially through prostaglandin E2- (PGE2-) and PKA-dependent phosphorylation of a specific subtype of glycine receptors (GlyRs) that contain α3 subunits. Here, we demonstrated that 2,6-di-tert-butylphenol (2,6-DTBP), a nonanesthetic propofol derivative, reverses inflammation-mediated disinhibition through a specific interaction with heteromeric αβGlyRs containing phosphorylated α3 subunits. We expressed mutant GlyRs in HEK293T cells, and electrophysiological analyses of these receptors showed that 2,6-DTBP interacted with a conserved phenylalanine residue in the membrane-associated stretch between transmembrane regions 3 and 4 of the GlyR α3 subunit. In native murine spinal cord tissue, 2,6-DTBP modulated synaptic, presumably αβ heteromeric, GlyRs only after priming with PGE2. This observation is consistent with results obtained from molecular modeling of the α-β subunit interface and suggests that in α3βGlyRs, the binding site is accessible to 2,6-DTBP only after PKA-dependent phosphorylation. In murine models of inflammatory pain, 2,6-DTBP reduced inflammatory hyperalgesia in an α3GlyR-dependent manner. Together, our data thus establish that selective potentiation of GlyR function is a promising strategy against chronic inflammatory pain and that, to our knowledge, 2,6-DTBP has a unique pharmacological profile that favors an interaction with GlyRs that have been primed by peripheral inflammation.
Journal of Biological Chemistry | 2012
Loreto San Martin; Fabian Cerda; Verónica A. Jiménez; Jorge Fuentealba; Braulio Muñoz; Luis G. Aguayo; Leonardo Guzmán
Background: Gβγ interaction with GlyR is an important determinant in ethanol potentiation of this channel. Results: A small peptide, RQHC7, can inhibit ethanol potentiation of GlyR currents. Conclusion: Results with RQHC7 indicate that ethanol mediated potentiation of GlyR is in part by Gβγ activation. Significance: Molecular interaction between Gβγ and GlyR could be used as a target for pharmacological modification of ethanol effects. Previous studies indicate that ethanol can modulate glycine receptors (GlyR), in part, through Gβγ interaction with basic residues in the intracellular loop. In this study, we show that a seven-amino acid peptide (RQHC7), which has the primary structure of a motif in the large intracellular loop of GlyR (GlyR-IL), was able to inhibit the ethanol-elicited potentiation of this channel from 47 ± 2 to 16 ± 4%, without interfering with the effect of Gβγ on GIRK (G protein activated inwardly rectifying potassium channel) activation. RQHC7 displayed a concentration-dependent effect on ethanol action in evoked and synaptic currents. A fragment of GlyR-IL without the basic amino acids did not interact with Gβγ or inhibit ethanol potentiation of GlyR. In silico analysis using docking and molecular dynamics allowed to identify a region of ∼350Å2 involving aspartic acids 186, 228, and 246 in Gβγ where we propose that RQHC7 binds and exerts its blocking action on the effect of ethanol in GlyR.
British Journal of Pharmacology | 2016
Cesar O. Lara; Pablo Murath; Braulio Muñoz; Ana M Marileo; Loreto San Martin; Victoria P San Martín; Carlos F. Burgos; Trinidad Mariqueo; Luis G. Aguayo; Jorge Fuentealba; Patricio Godoy; Leonardo Guzmán; Gonzalo E. Yévenes
Gelsemine is one of the principal alkaloids produced by the Gelsemium genus of plants belonging to the Loganiaceae family. The extracts of these plants have been used for many years, for a variety of medicinal purposes. Coincidentally, recent studies have shown that gelsemine exerts anxiolytic and analgesic effects on behavioural models. Several lines of evidence have suggested that these beneficial actions were dependent on glycine receptors, which are inhibitory neurotransmitter‐gated ion channels of the CNS. However, it is currently unknown whether gelsemine can directly modulate the function of glycine receptors.
Pharmacological Research | 2015
Carlos F. Burgos; Braulio Muñoz; Leonardo Guzmán; Luis G. Aguayo
It is well accepted that ethanol is able to produce major health and economic problems associated to its abuse. Because of its intoxicating and addictive properties, it is necessary to analyze its effect in the central nervous system. However, we are only now learning about the mechanisms controlling the modification of important membrane proteins such as ligand-activated ion channels by ethanol. Furthermore, only recently are these effects being correlated to behavioral changes. Current studies show that the glycine receptor (GlyR) is a susceptible target for low concentrations of ethanol (5-40mM). GlyRs are relevant for the effects of ethanol because they are found in the spinal cord and brain stem where they primarily express the α1 subunit. More recently, the presence of GlyRs was described in higher regions, such as the hippocampus and nucleus accumbens, with a prevalence of α2/α3 subunits. Here, we review data on the following aspects of ethanol effects on GlyRs: (1) direct interaction of ethanol with amino acids in the extracellular or transmembrane domains, and indirect mechanisms through the activation of signal transduction pathways; (2) analysis of α2 and α3 subunits having different sensitivities to ethanol which allows the identification of structural requirements for ethanol modulation present in the intracellular domain and C-terminal region; (3) Genetically modified knock-in mice for α1 GlyRs that have an impaired interaction with G protein and demonstrate reduced ethanol sensitivity without changes in glycinergic transmission; and (4) GlyRs as potential therapeutic targets.
Journal of Neurophysiology | 2014
Trinidad Mariqueo; Adolfo Agurto; Braulio Muñoz; Loreto San Martin; Cesar Coronado; Eduardo J. Fernández-Pérez; Pablo Murath; Andrea Sanchez; Gregg E. Homanics; Luis G. Aguayo
Neuropharmacology | 2011
Jorge Fuentealba; Braulio Muñoz; Gonzalo E. Yévenes; Gustavo Moraga-Cid; Claudia Pérez; Leonardo Guzmán; Jean Michel Rigo; Luis G. Aguayo
Archive | 2015
M. Katherine Kelm; Hugh E. Criswell; George R. Breese; Eduardo J. Fernández-Pérez; Pablo Murath; Andrea Sanchez; Gregg E. Homanics; Adolfo Agurto; Braulio Muñoz; Loreto San Martin; Cesar Coronado
Alcohol and Alcoholism | 2015
Luis G. Aguayo; Braulio Muñoz; B. Forstera; T. Mariqueo; L. San Martin; J. L. Guzman